Zdrowie i gospodarka · 23/05/2007

FDA Clears 27 Drug Products, Including Protamine Sulfate Injection, for Sale

The Food and Drug Administration (FDA) has determined that 27 drug products, including Protamine Sulfate Injection, were not withdrawn from sale due to safety or effectiveness concerns. This decision means the FDA will not initiate withdrawal procedures and will continue to approve Abbreviated New Drug Applications (ANDAs) for these products.